Ju‐Hee Bang

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

Hyerim Ha, Ah‐Rong Nam, Ju‐Hee Bang et al. · Oncotarget · 2016 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +17

Therapeutic implication of HER2 in advanced biliary tract cancer

Ah‐Rong Nam, Ji‐Won Kim, Yongjun Cha et al. · Oncotarget · 2016 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study assessing tolerability, efficacy, and biomarkers for durvalumab (D) ± tremelimumab (T) and gemcitabine/cisplatin (GemCis) in chemo-naïve advanced biliary tract cancer (aBTC).

Do‐Youn Oh, Kyung-Hun Lee, Dae‐Won Lee et al. · Journal of Clinical Oncology · 2020 · 80 citations

Medicine, Oncology, Pharmacology +17

Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

Sung‐Eun Lee, Soo Young Choi, Ju‐Hee Bang et al. · American Journal of Hematology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate

Sung‐Eun Lee, Soo Young Choi, Ju‐Hee Bang et al. · Cancer Genetics · 2012 · 25 citations

Life Sciences, Hematology, Oncology +16